The discovery reveals how bacteria silence potentially deadly genes.

A chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers.

A newly developed tool is studying the genetics underlying the emerging fungal pathogen, Candida auris.

A common mutation in a rare cancer subtype leads researchers to an already-approved drug that shows promise against uterine serous carcinoma.

Mouse model reveals gut inflammation makes it easier for bacterium to set up shop.

The method could help speed genetic discovery in the study of obesity.